BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 19394240)

  • 1. Survival benefit of boron neutron capture therapy for recurrent malignant gliomas.
    Miyatake S; Kawabata S; Yokoyama K; Kuroiwa T; Michiue H; Sakurai Y; Kumada H; Suzuki M; Maruhashi A; Kirihata M; Onoc K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S22-4. PubMed ID: 19394240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival benefit of Boron neutron capture therapy for recurrent malignant gliomas.
    Miyatake S; Kawabata S; Yokoyama K; Kuroiwa T; Michiue H; Sakurai Y; Kumada H; Suzuki M; Maruhashi A; Kirihata M; Ono K
    J Neurooncol; 2009 Jan; 91(2):199-206. PubMed ID: 18813875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
    Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
    Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boron neutron capture therapy combined with fractionated photon irradiation for glioblastoma: a recursive partitioning analysis of BNCT patients.
    Nakai K; Yamamoto T; Aiyama H; Takada T; Yoshida F; Kageji T; Kumada H; Isobe T; Endo K; Matsuda M; Tsurubuchi T; Shibata Y; Takano S; Mizumoto M; Tsuboi K; Matsumura A
    Appl Radiat Isot; 2011 Dec; 69(12):1790-2. PubMed ID: 21565517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical results of boron neutron capture therapy (BNCT) for glioblastoma.
    Kageji T; Mizobuchi Y; Nagahiro S; Nakagawa Y; Kumada H
    Appl Radiat Isot; 2011 Dec; 69(12):1823-5. PubMed ID: 21684170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy in supratentorial gliomas. A study of 821 cases.
    Heesters M; Molenaar W; Go GK
    Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical results of BNCT for malignant brain tumors in children.
    Nakagawa Y; Kageji T; Mizobuchi Y; Kumada H; Nakagawa Y
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S27-30. PubMed ID: 19406652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
    Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
    Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
    Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study.
    Kankaanranta L; Seppälä T; Koivunoro H; Välimäki P; Beule A; Collan J; Kortesniemi M; Uusi-Simola J; Kotiluoto P; Auterinen I; Serèn T; Paetau A; Saarilahti K; Savolainen S; Joensuu H
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):369-76. PubMed ID: 21236605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BNCT for recurrent intracranial meningeal tumours - case reports.
    Stenstam BH; Pellettieri L; Sorteberg W; Rezaei A; Sköld K
    Acta Neurol Scand; 2007 Apr; 115(4):243-7. PubMed ID: 17376121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of re-irradiation in malignant glioma: a single-center experience.
    Bartsch R; Weitmann HD; Pennwieser W; Wenzel C; Muschitz S; Baldass M; Hassler M; Marosi C; Rössler K; Pötter R; Dieckmann K
    Wien Klin Wochenschr; 2005 Dec; 117(23-24):821-6. PubMed ID: 16437319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current practices and future directions of therapeutic strategy in glioblastoma: survival benefit and indication of BNCT.
    Matsumura A; Yamamoto T; Tsurubuchi T; Matsuda M; Shirakawa M; Nakai K; Endo K; Tokuue K; Tsuboi K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S12-4. PubMed ID: 19375923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases.
    Miyatake S; Kawabata S; Hiramatsu R; Furuse M; Kuroiwa T; Suzuki M
    Radiat Oncol; 2014 Jan; 9():6. PubMed ID: 24387301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation injury of boron neutron capture therapy using mixed epithermal- and thermal neutron beams in patients with malignant glioma.
    Kageji T; Nagahiro S; Mizobuchi Y; Toi H; Nakagawa Y; Kumada H
    Appl Radiat Isot; 2004 Nov; 61(5):1063-7. PubMed ID: 15308193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boron Neutron Capture Therapy for glioblastoma multiforme: advantage of prolonged infusion of BPA-f.
    Sköld K; H-Stenstam B; Diaz AZ; Giusti V; Pellettieri L; Hopewell JW
    Acta Neurol Scand; 2010 Jul; 122(1):58-62. PubMed ID: 19951268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boron neutron capture therapy using mixed epithermal and thermal neutron beams in patients with malignant glioma-correlation between radiation dose and radiation injury and clinical outcome.
    Kageji T; Nagahiro S; Matsuzaki K; Mizobuchi Y; Toi H; Nakagawa Y; Kumada H
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1446-55. PubMed ID: 16750328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boron neutron capture therapy. Clinical brain tumor studies.
    Nakagawa Y; Hatanaka H
    J Neurooncol; 1997 May; 33(1-2):105-15. PubMed ID: 9151228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.
    Gabayan AJ; Green SB; Sanan A; Jenrette J; Schultz C; Papagikos M; Tatter SP; Patel A; Amin P; Lustig R; Bastin KT; Watson G; Burri S; Stea B
    Neurosurgery; 2006 Apr; 58(4):701-9; discussion 701-9. PubMed ID: 16575334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.